Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 1)*
|
Zeo Scientifix, Inc. (Name of Issuer) |
Common Stock, par value $0.001 (Title of Class of Securities) |
68621D206 (CUSIP Number) |
06/10/2026 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
| Rule 13d-1(c)
|
 Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. | 68621D206 |
| 1 | Names of Reporting Persons
Shapiro George Craig | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
1,311,271.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
15.1 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: (1) All calculations of percentage ownership herein are based upon an aggregate of 7,837,441 shares outstanding as of June 12, 2026, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended April 30, 2026, filed with the Securities and Exchange Commission on June 15, 2026.
SCHEDULE 13G
|
| Item 1. | |
| (a) | Name of issuer:
Zeo Scientifix, Inc. |
| (b) | Address of issuer's principal executive offices:
3321 College Avenue, Suite 246, Davie, FLORIDA, 33314. |
| Item 2. | |
| (a) | Name of person filing:
George Shapiro, M.D. |
| (b) | Address or principal business office or, if none, residence:
3321 College Avenue, Suite 246, Davie, FLORIDA, 33314. |
| (c) | Citizenship:
USA |
| (d) | Title of class of securities:
Common Stock, par value $0.001 |
| (e) | CUSIP No.:
|
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
1,311,271.00 |
| (b) |
Percent of class:
15.1% %
|
| (c) | Number of shares as to which the person has:
|
| (i) Sole power to vote or to direct the vote:
1,311,271.00 | |
| (ii) Shared power to vote or to direct the vote:
0 | |
| (iii) Sole power to dispose or to direct the disposition of:
1,311,271.00 | |
| (iv) Shared power to dispose or to direct the disposition of:
0 | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
Not Applicable
| |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not Applicable
| |
| Item 8. | Identification and Classification of Members of the Group. |
Not Applicable
| |
| Item 9. | Notice of Dissolution of Group. |
Not Applicable
|
| Item 10. | Certifications: |
Not Applicable
|
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|